Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease
Main Authors: | Cunnington, C, Van Assche, T, Shirodaria, C, Kylintireas, I, Lindsay, A, Lee, J, Antoniades, C, Margaritis, M, Lee, R, Cerrato, R, Crabtree, M, Francis, J, Sayeed, R, Ratnatunga, C, Pillai, R, Choudhury, R, Neubauer, S, Channon, K |
---|---|
Format: | Journal article |
Published: |
2012
|
Similar Items
-
Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease.
by: Cunnington, C, et al.
Published: (2012) -
Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease
by: Cunnington, C, et al.
Published: (2012) -
CHRONIC ORAL TETRAHYDROBIOPTERIN TREATMENT IN PATIENTS WITH CORONARY ARTERY DISEASE ELEVATES TOTAL BIOPTERIN LEVELS BUT DOES NOT IMPROVE BIOPTERIN REDOX STATUS OR VASCULAR FUNCTION: A RANDOMISED PLACEBO-CONTROLLED TRIAL
by: Cunnington, C, et al.
Published: (2010) -
Chronic oral tetrahydrobiopterin therapy in coronary artery disease elevates total biopterin levels but does not improve redox status or vascular function: a randomized placebo-controlled trial
by: Cunnington, C, et al.
Published: (2010) -
Low- and high- dose treatment with folic acid, equally improve endothelial function and decrease superoxide production in human vessels via tetrahydrobiopterin-mediated eNOS coupling
by: Antoniades, C, et al.
Published: (2007)